These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 17409364)

  • 1. Costs of rheumatoid arthritis: new estimates from the human capital method and comparison to the willingness-to-pay method.
    Fautrel B; Clarke AE; Guillemin F; Adam V; St-Pierre Y; Panaritis T; Fortin PR; Menard HA; Donaldson C; Penrod JR
    Med Decis Making; 2007; 27(2):138-50. PubMed ID: 17409364
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Valuing a hypothetical cure for rheumatoid arthritis using the contingent valuation methodology: the patient perspective.
    Fautrel B; Clarke AE; Guillemin F; Adam V; St-Pierre Y; Panaritis T; Fortin PR; Menard HA; Donaldson C; Penrod JR
    J Rheumatol; 2005 Mar; 32(3):443-53. PubMed ID: 15742435
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Indirect cost assessment in patients with rheumatoid arthritis (RA): comparison of data from the health economic patient questionnaire HEQ-RA and insurance claims data.
    Merkesdal S; Ruof J; Huelsemann JL; Mittendorf T; Handelmann S; Mau W; Zeidler H
    Arthritis Rheum; 2005 Apr; 53(2):234-40. PubMed ID: 15818718
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Use of the Stanford Health Assessment Questionnaire in estimation of long-term productivity costs in patients with recent-onset rheumatoid arthritis.
    Puolakka K; Kautiainen H; Mottonen T; Hannonen P; Korpela M; Hakala M; Luukkainen R; Vuori K; Blåfield H; Leirisalo-Repo M
    Scand J Rheumatol; 2009; 38(2):96-103. PubMed ID: 19274516
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Direct medical costs and their predictors in patients with rheumatoid arthritis: a three-year study of 7,527 patients.
    Michaud K; Messer J; Choi HK; Wolfe F
    Arthritis Rheum; 2003 Oct; 48(10):2750-62. PubMed ID: 14558079
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The economic burden of rheumatoid arthritis in a developing nation: results from a one-year prospective cohort study in Thailand.
    Osiri M; Maetzel A; Tugwell P
    J Rheumatol; 2007 Jan; 34(1):57-63. PubMed ID: 17183621
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Patient preferences for depression treatment programs and willingness to pay for treatment.
    Morey E; Thacher JA; Craighead WE
    J Ment Health Policy Econ; 2007 Jun; 10(2):73-85. PubMed ID: 17603148
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Willingness-to-pay for community-based insurance in Burkina Faso.
    Dong H; Kouyate B; Cairns J; Mugisha F; Sauerborn R
    Health Econ; 2003 Oct; 12(10):849-62. PubMed ID: 14508869
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Willingness to pay for drug abuse treatment: results from a contingent valuation study in Taiwan.
    Tang CH; Liu JT; Chang CW; Chang WY
    Health Policy; 2007 Jul; 82(2):251-62. PubMed ID: 17084480
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Productivity costs among patients with rheumatoid arthritis: the influence of methods and sources to value loss of productivity.
    Verstappen SM; Boonen A; Verkleij H; Bijlsma JW; Buskens E; Jacobs JW;
    Ann Rheum Dis; 2005 Dec; 64(12):1754-60. PubMed ID: 15860510
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Catastrophic health expenses and impoverishment of households of patients with rheumatoid arthritis.
    Álvarez-Hernández E; Peláez-Ballestas I; Boonen A; Vázquez-Mellado J; Hernández-Garduño A; Rivera FC; Teran-Estrada L; Ventura-Ríos L; Ramos-Remus C; Skinner-Taylor C; Goycochea-Robles MV; Bernard-Medina AG; Burgos-Vargas R
    Reumatol Clin; 2012; 8(4):168-73. PubMed ID: 22704914
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cost-utility analysis of treatment strategies in patients with recent-onset rheumatoid arthritis.
    van den Hout WB; Goekoop-Ruiterman YP; Allaart CF; de Vries-Bouwstra JK; Hazes JM; Kerstens PJ; van Zeben D; Hulsmans HM; de Jonge-Bok JM; de Sonnaville PB; Dijkmans BA; Breedveld FC
    Arthritis Rheum; 2009 Mar; 61(3):291-9. PubMed ID: 19248130
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Direct and indirect cost of general aviation crashes.
    Scuffham P; Chalmers D; O'Hare D; Wilson E
    Aviat Space Environ Med; 2002 Sep; 73(9):851-8. PubMed ID: 12234034
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Direct and indirect medical costs incurred by Canadian patients with rheumatoid arthritis: a 12 year study.
    Clarke AE; Zowall H; Levinton C; Assimakopoulos H; Sibley JT; Haga M; Shiroky J; Neville C; Lubeck DP; Grover SA; Esdaile JM
    J Rheumatol; 1997 Jun; 24(6):1051-60. PubMed ID: 9195508
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Is it possible to identify early predictors of the future cost of chronic arthritis? The VErA project.
    Flipon E; Brazier M; Clavel G; Boumier P; Gayet A; Le Loët X; Fardellone P;
    Fundam Clin Pharmacol; 2009 Feb; 23(1):105-13. PubMed ID: 19267774
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Out-of-pocket expenses and their burden in patients with rheumatoid arthritis.
    Wolfe F; Michaud K
    Arthritis Rheum; 2009 Nov; 61(11):1563-70. PubMed ID: 19877107
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Trends in economic consequences of rheumatoid arthritis over two subsequent years.
    Verstappen SM; Jacobs JW; Kruize AA; Ehrlich JC; van Albada-Kuipers GA; Verkleij H; Buskens E; Bijlsma JW
    Rheumatology (Oxford); 2007 Jun; 46(6):968-74. PubMed ID: 17337750
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Canadian estimates of health care utilization costs for rheumatoid arthritis patients with and without therapy with biologic agents.
    Ohinmaa AE; Thanh NX; Barnabe C; Martin L; Russell AS; Barr SG; Maksymowych WP
    Arthritis Care Res (Hoboken); 2014 Sep; 66(9):1319-27. PubMed ID: 24470178
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Willingness to pay for on-demand and prophylactic treatment for severe haemophilia in Sweden.
    Carlsson KS; Höjgård S; Lethagen S; Lindgren A; Berntorp E; Lindgren B
    Haemophilia; 2004 Sep; 10(5):527-41. PubMed ID: 15357780
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An assessment of the burden of migraine using the willingness to pay model.
    Hamelsky SW; Lipton RB; Stewart WF
    Cephalalgia; 2005 Feb; 25(2):87-100. PubMed ID: 15658945
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.